ID   ES-ZSS-1
AC   CVCL_E4C6
RX   PubMed=39475964;
CC   Population: Chinese.
CC   Characteristics: Established from a mice patient-derived xenograft (PubMed=39475964).
CC   Doubling time: ~61 hours (PubMed=39475964).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=39475964).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Gln963Serfs; Zygosity=Unspecified (PubMed=39475964).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Abdominal wall, hypodermis; UBERON=UBERON_0003697+UBERON_0002072.
ST   Source(s): PubMed=39475964
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 11,13
ST   D5S818: 9,11
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C7135; Extraskeletal Ewing sarcoma
DI   ORDO; Orphanet_370334; Extraskeletal Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
RX   PubMed=39475964; DOI=10.1007/s13577-024-01133-3;
RA   Zhang C.-L., Liu M.-L., Luan L.-J., Guo X., You Y., Wang Z.-M., Li W.,
RA   Lu N.-H., Hou Y.-Y., Lu L.-L., Lu W.-Q., Zhou Y.-H.;
RT   "Establishment and characterization of a patient-derived metastatic
RT   extraskeletal Ewing sarcoma cell line ES-ZSS-1.";
RL   Hum. Cell 38:12.1-12.9(2025).
//